Literature DB >> 24842903

Regulated proteolysis of NOTCH2 and NOTCH3 receptors by ADAM10 and presenilins.

Arjan J Groot1, Roger Habets1, Sanaz Yahyanejad1, Caroline M Hodin1, Karina Reiss2, Paul Saftig3, Jan Theys1, Marc Vooijs4.   

Abstract

In mammals, there are four NOTCH receptors and five Delta-Jagged-type ligands regulating many aspects of embryonic development and adult tissue homeostasis. NOTCH proteins are type I transmembrane receptors that interact with ligands on adjacent cells and are activated by regulated intramembrane proteolysis (RIP). The activation mechanism of NOTCH1 receptors upon ligand binding is well understood and requires cleavage by ADAM10 metalloproteases prior to intramembranous cleavage by γ-secretase. How the other human NOTCH receptor homologues are activated upon ligand binding is not known. Here, we dissect the proteolytic activation mechanism of the NOTCH2 and NOTCH3 receptors. We show that NOTCH2 and NOTCH3 signaling can be triggered by both Delta-Jagged-type ligands and requires ADAM10 and presenilin-1 or -2. Importantly, we did not find any role for the highly related ADAM17/TACE (tumor necrosis factor alpha-converting enzyme) protease in ligand-induced NOTCH2 or NOTCH3 signaling. These results demonstrate that canonical ligand-induced proteolysis of the NOTCH1, -2, and -3 receptors strictly depends on consecutive cleavage of these receptors by ADAM10 and the presenilin-containing γ-secretase complex, leading to transcriptional activation.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24842903      PMCID: PMC4135574          DOI: 10.1128/MCB.00206-14

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  60 in total

1.  Reduced Paneth cell antimicrobial protein levels correlate with activation of the unfolded protein response in the gut of obese individuals.

Authors:  Caroline M Hodin; Froukje J Verdam; Joep Grootjans; Sander S Rensen; Fons K Verheyen; Cornelis H C Dejong; Wim A Buurman; Jan Willem Greve; Kaatje Lenaerts
Journal:  J Pathol       Date:  2011-06-01       Impact factor: 7.996

2.  Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.

Authors:  Andrew P Weng; Adolfo A Ferrando; Woojoong Lee; John P Morris; Lewis B Silverman; Cheryll Sanchez-Irizarry; Stephen C Blacklow; A Thomas Look; Jon C Aster
Journal:  Science       Date:  2004-10-08       Impact factor: 47.728

3.  Mice lacking both presenilin genes exhibit early embryonic patterning defects.

Authors:  D B Donoviel; A K Hadjantonakis; M Ikeda; H Zheng; P S Hyslop; A Bernstein
Journal:  Genes Dev       Date:  1999-11-01       Impact factor: 11.361

4.  Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss.

Authors:  Michael A Simpson; Melita D Irving; Esra Asilmaz; Mary J Gray; Dimitra Dafou; Frances V Elmslie; Sahar Mansour; Sue E Holder; Caroline E Brain; Barbara K Burton; Katherine H Kim; Richard M Pauli; Salim Aftimos; Helen Stewart; Chong Ae Kim; Muriel Holder-Espinasse; Stephen P Robertson; William M Drake; Richard C Trembath
Journal:  Nat Genet       Date:  2011-03-06       Impact factor: 38.330

5.  Conservation of the biochemical mechanisms of signal transduction among mammalian Notch family members.

Authors:  T Mizutani; Y Taniguchi; T Aoki; N Hashimoto; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

6.  Direct observation of proteolytic cleavage at the S2 site upon forced unfolding of the Notch negative regulatory region.

Authors:  Natalie L Stephenson; Johanna M Avis
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-24       Impact factor: 11.205

7.  Cleavage of Notch1 by granzyme B disables its transcriptional activity.

Authors:  Geert van Tetering; Niels Bovenschen; Jan Meeldijk; Paul J van Diest; Marc Vooijs
Journal:  Biochem J       Date:  2011-07-15       Impact factor: 3.857

8.  Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency.

Authors:  A Herreman; D Hartmann; W Annaert; P Saftig; K Craessaerts; L Serneels; L Umans; V Schrijvers; F Checler; H Vanderstichele; V Baekelandt; R Dressel; P Cupers; D Huylebroeck; A Zwijsen; F Van Leuven; B De Strooper
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

9.  Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling.

Authors:  Esra Cagavi Bozkulak; Gerry Weinmaster
Journal:  Mol Cell Biol       Date:  2009-08-24       Impact factor: 4.272

10.  ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, L-selectin, and tumor necrosis factor alpha.

Authors:  Sylvain M Le Gall; Pierre Bobé; Karina Reiss; Keisuke Horiuchi; Xiao-Da Niu; Daniel Lundell; David R Gibb; Daniel Conrad; Paul Saftig; Carl P Blobel
Journal:  Mol Biol Cell       Date:  2009-01-21       Impact factor: 4.138

View more
  41 in total

Review 1.  ADAM Proteases and Gastrointestinal Function.

Authors:  Jennifer C Jones; Shelly Rustagi; Peter J Dempsey
Journal:  Annu Rev Physiol       Date:  2015-11-19       Impact factor: 19.318

2.  ADAM10-Dependent Signaling Through Notch1 and Notch4 Controls Development of Organ-Specific Vascular Beds.

Authors:  Rolake O Alabi; Krzysztof Glomski; Coline Haxaire; Gisela Weskamp; Sébastien Monette; Carl P Blobel
Journal:  Circ Res       Date:  2016-06-27       Impact factor: 17.367

Review 3.  Role of ADAM10 in intestinal crypt homeostasis and tumorigenesis.

Authors:  Peter J Dempsey
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-07-22       Impact factor: 4.739

4.  New insights into the tetraspanin Tspan5 using novel monoclonal antibodies.

Authors:  Julien Saint-Pol; Martine Billard; Emmanuel Dornier; Etienne Eschenbrenner; Lydia Danglot; Claude Boucheix; Stéphanie Charrin; Eric Rubinstein
Journal:  J Biol Chem       Date:  2017-04-20       Impact factor: 5.157

5.  The metalloprotease ADAM10 (a disintegrin and metalloprotease 10) undergoes rapid, postlysis autocatalytic degradation.

Authors:  Tobias Brummer; Martina Pigoni; Armando Rossello; Huanhuan Wang; Peter J Noy; Michael G Tomlinson; Carl P Blobel; Stefan F Lichtenthaler
Journal:  FASEB J       Date:  2018-02-07       Impact factor: 5.191

6.  Sustained Notch2 signaling in osteoblasts, but not in osteoclasts, is linked to osteopenia in a mouse model of Hajdu-Cheney syndrome.

Authors:  Stefano Zanotti; Jungeun Yu; Archana Sanjay; Lauren Schilling; Chris Schoenherr; Aris N Economides; Ernesto Canalis
Journal:  J Biol Chem       Date:  2017-06-07       Impact factor: 5.157

7.  Ttyh1 regulates embryonic neural stem cell properties by enhancing the Notch signaling pathway.

Authors:  Juwan Kim; Dasol Han; Sung-Hyun Byun; Mookwang Kwon; Jae Youl Cho; Samuel J Pleasure; Keejung Yoon
Journal:  EMBO Rep       Date:  2018-09-03       Impact factor: 8.807

8.  Notch signaling promotes osteoclast maturation and resorptive activity.

Authors:  Jason W Ashley; Jaimo Ahn; Kurt D Hankenson
Journal:  J Cell Biochem       Date:  2015-11       Impact factor: 4.429

9.  NOTCH3 is non-enzymatically fragmented in inherited cerebral small-vessel disease.

Authors:  Kelly Z Young; Soo Jung Lee; Xiaojie Zhang; Naw May Pearl Cartee; Mauricio Torres; Simon G Keep; Sairisheel R Gabbireddy; Julia L Fontana; Ling Qi; Michael M Wang
Journal:  J Biol Chem       Date:  2020-01-04       Impact factor: 5.157

10.  Human-Specific NOTCH2NL Genes Affect Notch Signaling and Cortical Neurogenesis.

Authors:  Ian T Fiddes; Gerrald A Lodewijk; Meghan Mooring; Colleen M Bosworth; Adam D Ewing; Gary L Mantalas; Adam M Novak; Anouk van den Bout; Alex Bishara; Jimi L Rosenkrantz; Ryan Lorig-Roach; Andrew R Field; Maximilian Haeussler; Lotte Russo; Aparna Bhaduri; Tomasz J Nowakowski; Alex A Pollen; Max L Dougherty; Xander Nuttle; Marie-Claude Addor; Simon Zwolinski; Sol Katzman; Arnold Kriegstein; Evan E Eichler; Sofie R Salama; Frank M J Jacobs; David Haussler
Journal:  Cell       Date:  2018-05-31       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.